查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1967822

2026-2034年全球心臟節律管理設備市場規模、佔有率、趨勢和成長分析報告

Global Cardiac Rhythm Management Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計到 2034 年，心臟節律管理設備的市場規模將從 2025 年的 279.5 億美元成長至 449.8 億美元，2026 年至 2034 年的複合年成長率為 5.43%。

全球心臟節律管理（CRM）市場，包括心律調節器、植入式心臟整流去顫器（ICD）和心臟再同步治療設備，由於人口老化和心律不整篩檢的增加而持續成長。設備小型化、電池壽命延長和無導線心律調節器技術的進步正在擴大臨床應用，而遠端監測能力的提升則增強了植入後的護理。此外，新興市場心血管疾病盛行率的上升和心臟護理服務的改善也推動了這一成長。

關鍵成長要素包括人口老化、心臟衰竭和心律不整盛行率上升、診斷流程改善以及器械治療報銷範圍擴大。技術創新（無導線起搏、皮下植入式ICD、MRI相容設備和先進遙測技術）減少了手術併發症，並提高了患者的生活品質。此外，與數位健康平台和數據分析的互通性實現了早期療育和最佳化治療管理，從而影響了臨床醫生對現代CRM系統的偏好。

展望未來，重點將放在個人化治療、持續小型化以及與遠距患者管理的整合。無導線多心室節律器、長壽命電池或能源採集解決方案以及人工智慧驅動的心律不整檢測技術將定義下一代產品的形式。在新興市場，隨著基礎設施和專家的擴展，銷售額預計將會成長。由於價格壓力、監管審查的加強以及來自微創替代療法的競爭，製造商必須專注於臨床差異化、療效數據和基於價值的契約，以維持長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球心臟節律管理設備市場：依產品分類

  • 市場分析、洞察與預測
  • 心律調節器
  • 去心房顫動
  • 心臟再同步治療裝置

第5章 全球心臟節律管理設備市場：依應用領域分類

  • 市場分析、洞察與預測
  • 鬱血性心臟衰竭
  • 心律不整
  • 心搏過緩
  • 心搏過速
  • 其他用途

第6章 全球心臟節律管理設備市場：依最終用途分類

  • 市場分析、洞察與預測
  • 醫院
  • 心臟護理中心
  • 門診手術中心
  • 其他最終用途

第7章 全球心臟節律管理設備市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Abbott Laboratories
    • Abiomed Inc
    • AMI Italia SRL
    • Asahi Kasei Corporation
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • BPL Medical Technologies
    • CU Medical Inc
    • Defibtech LLC
    • LivaNova Plc
    • Medico GmbH
簡介目錄
Product Code: VMR11218634

The Cardiac Rhythm Management Devices Market size is expected to reach USD 44.98 Billion in 2034 from USD 27.95 Billion (2025) growing at a CAGR of 5.43% during 2026-2034.

The global cardiac rhythm management (CRM) market, encompassing pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy devices, has expanded due to aging populations and greater screening for arrhythmias. Advances in device miniaturization, battery longevity, and leadless pacemaker technologies have broadened clinical adoption, while remote monitoring capabilities have improved post-implant care. Growth has been further supported by rising cardiovascular disease prevalence and better access to cardiac care in emerging markets.

Major growth drivers include demographic aging, increasing prevalence of heart failure and arrhythmias, improved diagnostic pathways, and reimbursement expansions for device therapies. Technological innovations-leadless pacing, subcutaneous ICDs, MRI-conditional devices, and enhanced telemetry-reduce procedural complications and enhance patient quality of life. Additionally, interoperability with digital health platforms and data analytics enables earlier intervention and optimized therapy management, influencing clinician preference toward modern CRM systems.

Future outlook emphasizes personalized therapies, continued miniaturization, and integration with remote patient management. Leadless multi-chamber pacing, longer-life batteries or energy-harvesting solutions, and AI-driven arrhythmia detection will shape next-generation offerings. Emerging markets will contribute incremental sales as infrastructure and trained specialists expand. Pricing pressures, regulatory scrutiny, and competition from minimally invasive alternatives will require manufacturers to focus on clinical differentiation, outcomes data, and value-based contracting to sustain long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Pacemakers
  • Defibrillators
  • Cardiac Resynchronization Therapy Devices

By Application

  • Congestive Heart Failure
  • Arrhythmias
  • Bradycardia
  • Tachycardia
  • Other Applications

By End Use

  • Hospitals
  • Cardiac Care Centers
  • Ambulatory Surgical Centers
  • Other End Use

COMPANIES PROFILED

  • Abbott Laboratories, Abiomed Inc, AMI Italia Srl, Asahi Kasei Corporation, Biotronik SE Co KG, Boston Scientific Corporation, BPL Medical Technologies, CU Medical Inc, Defibtech LLC, LivaNova plc, Medico GmbH
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Pacemakers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Defibrillators Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Cardiac Resynchronization Therapy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Congestive Heart Failure Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Arrhythmias Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Bradycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Tachycardia Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY END USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End Use
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Cardiac Care Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Other End Use Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End Use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End Use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End Use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End Use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End Use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CARDIAC RHYTHM MANAGEMENT DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Abbott Laboratories
    • 9.2.2 Abiomed Inc
    • 9.2.3 AMI Italia S.R.L
    • 9.2.4 Asahi Kasei Corporation
    • 9.2.5 Biotronik SE & Co. KG
    • 9.2.6 Boston Scientific Corporation
    • 9.2.7 BPL Medical Technologies
    • 9.2.8 CU Medical Inc
    • 9.2.9 Defibtech LLC
    • 9.2.10 LivaNova Plc
    • 9.2.11 Medico GmbH